by Lance Smith | Apr 12, 2019 | Study Scavenger Clinical Trial Recruitment Platform
SC Liver Research Consortium and Perspectum Diagnostics develop major US clinical network This will provide clinical trial services supporting drug development for liver disorders SC Liver Research Consortium (SC Liver) and Perspectum Diagnostics have developed a...by Lance Smith | Apr 12, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Patient recruitment is essential to the clinical trial process. Without patients to participate, a trial can’t become a reality. Sometimes, sites take on a study and lack the planning or resources to enroll an adequate amount of patients. Clinical trial...by Lance Smith | Apr 10, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Nordic Nanovector ASA (OSE: NANO) announces that the Safety Review Committee (SRC) for the ongoing LYMRIT 37-05 clinical trial of single-administration Betalutin® (177Lu-satetraxetan-lilotomab) in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL)...by Lance Smith | Apr 10, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Peloton Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing first-in-class oral medicines for cancer and other serious conditions, announced the completion of patient enrollment in a Phase 2 clinical trial evaluating the efficacy and safety of its...by Lance Smith | Apr 10, 2019 | Study Scavenger Clinical Trial Recruitment Platform
OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) announces that it has strengthened its intellectual property rights for its Phase 2-ready product FR104, a monoclonal antibody antagonist of CD28, through the granting of a patent by the Canadian Intellectual...by Lance Smith | Apr 10, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Primary safety endpoint met as FX-322 was well tolerated Preliminary clinical data suggests improvement on measures of hearing function Company now planning Phase 2 Study to commence later this year WOBURN, Mass.–(BUSINESS WIRE)– Frequency Therapeutics, a...